Reactome | golimumab [extracellular region]

Schema > ProteinDrug > Entries

authored	[InstanceEdit:9714531] Stephan, Ralf, 2021-02-12
compartment	[Compartment:984] extracellular region
created	[InstanceEdit:9715007] Stephan, Ralf, 2021-02-16
crossReference	[DatabaseIdentifier:12021174] Mondo:0005101
dbId	9714993
disease	[Disease:5663017] rheumatoid arthritis [Disease:9660843] psoriatic arthritis [Disease:9660847] juvenile rheumatoid arthritis [Disease:9660849] ankylosing spondylitis [Disease:9625953] ulcerative colitis
displayName	golimumab [extracellular region]
inDisease	true
literatureReference	[LiteratureReference:9714940] Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor ? [LiteratureReference:9714920] Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
maxDepth	1
memberOf	[DefinedSet:R-ALL-9714904] TNF-alpha inhibitors [extracellular region]
name	golimumab
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:6776] golimumab [Guide to Pharmacology:6776]
schemaClass	ProteinDrug
stId	R-ALL-9714993

(hasMember)